The controversial Medicare prescription drug benefit is a year old and seems to be a success. The Wall Street Journal's David Wessel talks with Renee Montagne about the program.
Copyright 2022 NPR. To see more, visit https://www.npr.org. 9(MDAzMjM2NDYzMDEyMzc1Njk5NjAxNzY3OQ001))
Play Live Radio
Next Up:
0:00
0:00
